CHINA'S REGULATION OF BIOTECHNOLOGY - DOES IT CONFORM TO THE WTO?

Laura J. Loppacher and William Kerr

No 23938, Reports from Estey Centre for Law and Economics in International Trade

Abstract: The People's Republic of China has been working for over two decades to develop a domestic biotechnology industry. Even though China is a developing country, it is set to become a significant international player in the field of biotechnology. China's accession to the World Trade Organization in December of 2001 means that China's trade and regulatory regime should now reflect its WTO commitments. This paper outlines the development of the Chinese biotechnology industry and how it may evolve in the future. It assesses China's current approach to trade and regulation of biotechnology in relation to GATT rules on trade in goods and the TRIPS commitments pertaining to the protection of intellectual property. The conclusion is that China's trade and intellectual property regimes currently deviate considerably from WTO norms and number of trade disputes are likely to arise in the near future.

Keywords: International; Relations/Trade (search for similar items in EconPapers)
Pages: 43
Date: 2004
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://ageconsearch.umn.edu/record/23938/files/pa04lo03.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ags:eclere:23938

DOI: 10.22004/ag.econ.23938

Access Statistics for this paper

More papers in Reports from Estey Centre for Law and Economics in International Trade Contact information at EDIRC.
Bibliographic data for series maintained by AgEcon Search ().